tiprankstipranks
TipRanksTop Financial ExpertsInsidersBridgeBio Pharma LLC

BridgeBio Pharma LLC Insider Profile

4 Followers
BridgeBio Pharma LLC, Ten Percent Owner at Eidos Therapeutics, holds 24.58M shares in Eidos Therapeutics (Ticker: EIDX). Most recently, BridgeBio Pharma LLC Bought 882,353 shares of Eidos Therapeutics on Jul 08, 2019 for an estimated value of $26.38M.
See the Hottest Stocks Based on Insider Trading >
tipranks
BridgeBio Pharma LLC

BridgeBio Pharma LLC
Eidos Therapeutics (EIDX)
Ten Percent Owner

Ranked #335 out of 107,514 Corporate Insiders

Profitable Transactions

100%
6 out of 6 Profitable Transactions

Average Return

+187.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

BridgeBio Pharma LLC does not currently own shares as a corporate insider.
A breakdown of BridgeBio Pharma LLC's holdings
See the Top Stocks by Insiders

Insider Roles

BridgeBio Pharma LLC does not currently hold a role as a corporate insider.
Roles that BridgeBio Pharma LLC holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Eidos Therapeutics
(EIDX)
Rating:Informative Buy
Date:Dec 06, 2018 - Dec 06, 2019
Return:+342.90%
The most profitable trade made by BridgeBio Pharma LLC
See the Latest Stocks Traded by Insiders

BridgeBio Pharma LLC's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
EIDX
Eidos Therapeutics
Jul 08, 2019
―
Informative Buy
26.38M
$3.00B
EIDX
is no longer traded
Success Rate for
EIDX
6 out of 6 profitable transactions on
EIDX
100%
Average Return for
EIDX
Average return per transaction on
EIDX
+187.83%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jun 26, 2018
Uninformative Buy
$3.60M
18,826,417
$0.00
―
Jun 26, 2018
Informative Buy
$17.00M
1,000,000
$17.00
+30.60%
Dec 06, 2018
Informative Buy
$42.59M
2,853,848
$14.92
+342.90%
Dec 10, 2018
Informative Buy
$1.10M
80,144
$13.67
+332.70%
Dec 12, 2018
Informative Buy
$542.06K
40,653
$13.33
+328.80%
List of latest transactions for each holding click on a transaction to see BridgeBio Pharma LLC's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

BridgeBio Pharma LLC insider profile FAQ

What is the percentage of profitable transactions made by BridgeBio Pharma LLC?
The percentage of profitable transactions made by BridgeBio Pharma LLC is 100%.
    What is the average return per transaction made by BridgeBio Pharma LLC?
    The average return per transaction made by BridgeBio Pharma LLC is 187.80%.
      What stocks does BridgeBio Pharma LLC hold?
      BridgeBio Pharma LLC holds: EIDX stocks.
        What was BridgeBio Pharma LLC’s latest transaction?
        BridgeBio Pharma LLC latest transaction was an Informative Buy of $26.38M.
          What was BridgeBio Pharma LLC's most profitable transaction?
          BridgeBio Pharma LLC’s most profitable transaction was an Informative Buy of EIDX stock on December 6, 2018. The return on the trade was 342.90%.
            What is BridgeBio Pharma LLC's role in Eidos Therapeutics?
            BridgeBio Pharma LLC's role in Eidos Therapeutics is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.